Literature DB >> 8461629

Allopurinol and oxypurinol in human breast milk.

I Kamilli1, U Gresser.   

Abstract

To pregnant or breast feeding women drugs should be given with caution. We report the case of a 5-week-old breast-fed infant whose mother was taking 300mg allopurinol/day for 4 weeks. Allopurinol and oxypurinol were detected by HPLC in maternal plasma and breast milk with a method first described here. In infant's plasma taken 2 h after breast feeding oxypurinol was found; allopurinol was below the limit of detection. The milk/plasma ratio in the mother 2 h (4 h) after drug ingestion was 0.9 (1.4) for allopurinol and 3.9 (2.4) for oxypurinol. The average daily dose for the baby of allopurinol was 0.14-0.20 mg/kg and that of oxypurinol 7.2-8.0 mg/kg by ingestion of breast milk after oral intake of allopurinol by the mother.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461629     DOI: 10.1007/bf00179999

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  19 in total

1.  Allopurinol in breast milk.

Authors:  I Kamilli; U Gresser; C Schaefer; N Zöllner
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  The effect of dietary protein on the clearance of allopurinol and oxypurinol.

Authors:  W G Berlinger; G D Park; R Spector
Journal:  N Engl J Med       Date:  1985-09-26       Impact factor: 91.245

3.  Determination of allopurinol and oxipurinol in biological fluids by high-performance liquid chromatography.

Authors:  H Breithaupt; G Goebel
Journal:  J Chromatogr       Date:  1981-11-13

4.  Drug 'administration' via breast milk.

Authors:  A C Platzker; C D Lew; D Stewart
Journal:  Hosp Pract       Date:  1980-09

5.  Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.

Authors:  G B Elion; A Kovensky; G H Hitchings
Journal:  Biochem Pharmacol       Date:  1966-07       Impact factor: 5.858

6.  A prospective study of cow's milk protein intolerance in Swedish infants.

Authors:  I Jakobsson; T Lindberg
Journal:  Acta Paediatr Scand       Date:  1979-11

7.  Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration.

Authors:  S J Appelbaum; M Mayersohn; R T Dorr; D Perrier
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  [Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)].

Authors:  I Walter-Sack; W Gröbner; N Zöllner
Journal:  Arzneimittelforschung       Date:  1979

Review 9.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

Review 10.  Pharmacologic considerations of drug use in the lactating mother.

Authors:  C M Berlin
Journal:  Obstet Gynecol       Date:  1981-11       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.